GCG and metabolic syndrome: Most of the patients had comorbilities such as dyslipidemia and/or hypertension; half of the patients had been diagnosed with T2DM for over 13 years and used oral antidiabetics (OAD), with a predominance of iSGLT2 and GLP1-RA.